BSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹891.00
- Market cap
- ₹5,336 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 615.6×Sector 46.1×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Orchid Pharma Annual General Meeting
Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.
Other capital structure change announcements
All →Panache Digilife Capital Structure Change
Panache Digilife invested Rs 2.25 Crore via rights issue in wholly owned subsidiary Technofy Digital. The subsidiary remains 100% owned, with nil turnover reported.
- Value
- ₹2.25 Cr
Greenply Industries Capital Structure Change
Greenply Industries will invest up to Rs.30 Crore cash in wholly owned subsidiary Greenply Sandila. Funds will expand plywood capacity, paid in tranches through Q4 FY2028.
- Value
- ₹30.00 Cr
- Execution
- By Q4 of FY 2028, in one or more tranches
Restaurant Brands Asia Capital Structure Change
Restaurant Brands Asia will subscribe up to ₹131.23 Crore in preference shares of its Indonesian subsidiary. The cash infusion funds PT Sari Burger's business needs.
- Value
- ₹131.2 Cr
- Execution
- Tranches; indicative completion by 30-06-2027
DCW Capital Structure Change
DCW Limited's board approved an open-market buyback of up to 68.97 lakh shares at Rs 58 each. The maximum buyback size is Rs 40 Crore.
- Value
- ₹40.00 Cr
Kajaria Ceramics Capital Structure Change
Kajaria Ceramics will subscribe Rs 4.5 Crore of preference shares in step-down subsidiary Kerovit Global, improving its debt-equity ratio. The related party deal is at arm's length.
- Value
- ₹4.50 Cr
Kajaria Ceramics Capital Structure Change
Kajaria Ceramics subscribed Rs 45 Crore of NCRPS in step-down subsidiary KGPL to improve its debt-equity ratio. KGPL remains a wholly-owned subsidiary; no entity is acquired.
- Value
- ₹45.00 Cr